Stay updated on TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin
Sign up to get notified when there's something new on the TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin page.
Latest updates to the TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedPublication section wording was revised from 'are about the study results' to 'are about the results of the study,' a minor textual update to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check19 days agoChange DetectedThe banner regarding government funding and operating status was removed from the page.SummaryDifference0.5%
- Check26 days agoChange DetectedLast update posted date updated to 2025-02-24 with minor textual edits; no changes to study design, eligibility criteria, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check33 days agoChange DetectedThe new screenshot shows only minor metadata updates on the TNT trial page, with no changes to the study design, endpoints, eligibility criteria, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check40 days agoChange DetectedEditorial updates only; there are no changes to inclusion criteria, endpoints, enrollment, or study design. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check55 days agoChange DetectedNo changes detected. The page appears to be unchanged.SummaryDifference0.2%
Stay in the know with updates to TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin
Enter your email address, and we'll notify you when there's something new on the TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin page.